Fibrinogen reduction and bleeding complications in plasma exchange, immunoadsorption and a combination of the two.

Background: Immunoadsorption (IAS) and therapeutic plasma exchange (TPE) are considered safe although fibrinogen is removed. To date no comparison of fibrinogen r